Skip to main content

Liraglutide

GLP-1 receptor agonist

Also known as: Victoza, Saxenda

Liraglutide

₦250,000–₦550,000

Verify
On this page

Key Facts

Drug Class
GLP-1 receptor agonist
Prescription
Required
NAFDAC Status
Check Registration
Forms
Injection (pen)
Price Range
₦250,000 - ₦550,000

What is Liraglutide?

Liraglutide is a GLP-1 receptor agonist — the older, longer-established cousin of semaglutide (Ozempic). Made by Novo Nordisk, it is sold as Victoza, licensed for type-2 diabetes, and as Saxenda, licensed for weight management. Unlike the weekly semaglutide injections, liraglutide is injected once every day. It lowers blood sugar and reduces appetite, and it has a longer track record than the newer GLP-1s.

Liraglutide works the same way as other GLP-1 drugs: it mimics the gut hormone GLP-1, prompting the pancreas to release insulin when blood sugar is high, slowing stomach emptying, and acting on appetite centres in the brain so you feel full and eat less. For type-2 diabetes (Victoza) this improves blood sugar control and often trims weight; for obesity (Saxenda) the appetite effect is the goal. It is a prescription medicine, started low and increased gradually to limit nausea, and it should be supervised by a doctor.

In Nigeria, liraglutide is imported and expensive, though a daily pen pack often costs somewhat less than the flashier weekly brands like Ozempic or Mounjaro. Saxenda is registered with NAFDAC, which is reassuring — but the same cautions apply as for all GLP-1s: keep the pens refrigerated, buy only from a licensed pharmacy, verify the NAFDAC number, and be wary of cheap online or social-media offers, because counterfeit and badly stored weight-loss pens are widespread. It is a medical treatment for diabetes or obesity, not a casual slimming aid.

What is Liraglutide used for?

In Nigeria, Liraglutide is commonly used for:

  • Type-2 diabetes — lowering blood sugar, usually alongside metformin (Victoza)
  • Chronic weight management in obesity, with diet and exercise (Saxenda)
  • Reducing cardiovascular risk in people with type-2 diabetes and heart disease
  • Appetite and portion control through gut and brain signalling
  • A daily GLP-1 option for people who prefer it or cannot access the weekly injections

Dosage

IMPORTANT

Always follow your doctor's or pharmacist's instructions. The information below is for general reference only.

Adults

Liraglutide is injected once daily under the skin, at any time of day, and the dose is increased step by step. Victoza (diabetes) usually starts at 0.6mg daily for a week, then 1.2mg, up to a maximum of 1.8mg. Saxenda (weight loss) climbs weekly from 0.6mg through to 3mg daily. Rotate the injection site (abdomen, thigh, upper arm). Your doctor sets the schedule — increasing too fast worsens nausea.

Children

Not routinely used in children in Nigeria; any adolescent use must be specialist-led.

Elderly

Can be used in older adults with monitoring for dehydration from nausea/vomiting and for kidney function.

Inject at roughly the same time each day and keep a routine, since it is daily rather than weekly. Store unopened pens in the fridge and do not freeze; an in-use pen can usually be kept for a limited number of days per the label. If you miss a dose, resume the next day at the usual dose — do not double up. Nausea is common early on and eases with time and smaller, lower-fat meals.

Side Effects

Common side effects

  • Nausea — very common at first, usually improving over time
  • Vomiting, diarrhoea, or constipation
  • Reduced appetite and early fullness
  • Headache or tiredness
  • Injection-site reactions

Serious side effects — seek medical help immediately

  • Severe, persistent abdominal pain with vomiting — possible pancreatitis; stop and seek urgent care
  • Gallbladder problems: upper-right abdominal pain, fever, or yellowing of the skin/eyes
  • Low blood sugar, especially with insulin or a sulfonylurea: shakiness, sweating, confusion
  • Signs of dehydration or kidney strain from heavy vomiting/diarrhoea
  • A neck lump, hoarseness, or trouble swallowing (rare thyroid concern)
  • Serious allergic reaction: swelling of the face or throat, difficulty breathing

When to see a doctor

Seek urgent care for severe or persistent abdominal pain, repeated vomiting with dehydration, or signs of a serious allergic reaction. Contact your doctor if nausea stops you eating or drinking, if you have symptoms of low blood sugar, or if you notice neck swelling. Tell any doctor or anaesthetist you take liraglutide before surgery or sedation, as GLP-1 drugs slow stomach emptying.

Warnings & Precautions

Do not take Liraglutide if you have:

  • Do not use in type-1 diabetes or for diabetic ketoacidosis
  • Do not use if you have had medullary thyroid cancer, a family history of it, or MEN 2
  • Avoid if you have had pancreatitis, unless a specialist advises otherwise
  • Do not use in pregnancy or while breastfeeding
  • Do not use if you are allergic to liraglutide

Drug interactions

  • Insulin and sulfonylureas (e.g. glibenclamide): higher risk of low blood sugar — doses may need lowering
  • Slowed stomach emptying can affect absorption of other oral medicines
  • Severe vomiting can reduce the reliability of oral contraceptive pills — use backup if unwell
  • Drugs needing monitoring (e.g. warfarin) may need closer checks when starting

Pregnancy & Breastfeeding

Liraglutide must not be used in pregnancy or while breastfeeding, and should be stopped before trying to conceive. As with all weight-loss GLP-1s, improved fertility with weight loss can lead to unplanned pregnancy, so use reliable contraception. Stop the medicine and tell your doctor if you become pregnant.

Brands of Liraglutide in Nigeria

The NAFDAC registry holds 2 Liraglutide products from 2 manufacturers, including combination products and older listings whose status you can check in the full list. Below are some of the most common brands — see the full, searchable list for all of them.

Brand NameManufacturerStrengthForm
VictozaNovo Nordisk6mg/mlInjection (pen)
SaxendaNovo Nordisk6mg/mlInjection (pen)

How to Verify Your Liraglutide is Genuine

  1. 1Buy only from a licensed pharmacy — weight-loss pens are heavily counterfeited
  2. 2Check the NAFDAC registration number on the pack and verify it on the NAFDAC Green Book or app (Saxenda is NAFDAC-registered)
  3. 3Be very suspicious of low prices — genuine liraglutide costs hundreds of thousands of naira; a cheap pen is a red flag for a fake
  4. 4Insist on refrigerated (cold-chain) storage; refuse pens sold warm or from an unrefrigerated stall
  5. 5Check the pen, label, expiry, and batch number; reject anything with spelling errors, blurry printing, or tampered packaging
  6. 6Avoid social-media sellers and 'weight-loss coaches' — this is a prescription medicine needing a real pharmacy and a doctor

Liraglutide Price in Nigeria

Liraglutide prices in Nigeria typically range from ₦250,000 to ₦550,000 per pen pack, depending on the brand, strength, and where you buy it.

250,000550,000

per pen pack

Prices vary by location and vendor. Last updated: 2026-07-18

Where to Buy

Purchase Liraglutide only from licensed pharmacies and verified distributors. Avoid buying medicines from unverified sources, roadside vendors, or unregistered market stalls.

Before you buy, verify the product's NAFDAC registration and check the current online prices above so you know a fair price before you pay.

Buying Liraglutide in bulk or for resale? Our guide on how to buy medicines in bulk in Nigeria safely covers verifying a supplier and spotting fakes before a large order.

Need Liraglutide in bulk, or can't find it near you?

Tell us what you need and we'll connect you with a verified, NAFDAC-registered source.

Request it

Related Resources for Liraglutide

Guides, articles, and tools related to Liraglutide and other diabetes medicines in Nigeria.

Frequently Asked Questions

Sources

  • NAFDAC Greenbook — the official database of all products registered with Nigeria's National Agency for Food and Drug Administration and Control. Brand-level NAFDAC numbers for Liraglutide on this page were cross-referenced against the Greenbook.
  • British National Formulary (BNF) dosing and interaction guidance for Liraglutide.
  • Nigerian Standard Treatment Guidelines (Federal Ministry of Health).

Last updated: 18 July 2026

Share: